SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2014. The put-call ratio across all filers is 2.83 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $7,000 | -96.6% | 29,392 | -95.0% | 0.00% | – |
| Q4 2015 | $206,000 | -73.6% | 586,346 | +30.9% | 0.00% | – |
| Q3 2015 | $780,000 | -34.0% | 447,856 | -15.5% | 0.00% | – |
| Q2 2015 | $1,182,000 | -47.5% | 530,231 | -54.3% | 0.00% | -100.0% |
| Q1 2015 | $2,252,000 | -0.4% | 1,160,562 | +36.0% | 0.00% | – |
| Q4 2014 | $2,261,000 | -34.1% | 853,294 | -25.1% | 0.00% | -100.0% |
| Q3 2014 | $3,429,000 | -31.4% | 1,139,509 | -6.8% | 0.00% | -50.0% |
| Q2 2014 | $5,002,000 | +4.8% | 1,223,058 | +10.5% | 0.00% | 0.0% |
| Q1 2014 | $4,771,000 | -22.4% | 1,106,821 | -5.7% | 0.00% | -33.3% |
| Q4 2013 | $6,147,000 | +3.7% | 1,173,201 | +24.9% | 0.00% | 0.0% |
| Q3 2013 | $5,929,000 | +23.9% | 939,640 | -2.0% | 0.00% | +50.0% |
| Q2 2013 | $4,784,000 | – | 958,592 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
| Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
| NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
| Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
| SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
| Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
| Roundview Capital LLC | 21,100 | $91,000 | 0.04% |